Skip to content

Privacy Policy

Besttirzepatideonline does not collect personal data on this site. Analytics is aggregated and anonymous.

Reviewed by the Besttirzepatideonline Research Team · Last updated April 2026

References & Scientific Sources

  1. Jastreboff AM, et al. Tirzepatide once weekly for obesity (SURMOUNT-1). N Engl J Med. 2022.
  2. Frias JP, et al. Tirzepatide vs semaglutide in type 2 diabetes (SURPASS-2). N Engl J Med. 2021.
  3. Rosenstock J, et al. Efficacy and safety of tirzepatide monotherapy (SURPASS-1). Lancet. 2021.

Sources are provided for educational reference. This content is informational and not a substitute for professional medical advice.